AstraZeneca Pharma Q3: Revenue Soars Due to Oncology, Biopharma; Profit Margins Slip

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

AstraZeneca Pharma Q3 Revenue Soars 39% on Oncology, Biopharma Growth; Margins Slip

AstraZeneca Pharma Q3 Revenue Soars 39% on Oncology, Biopharma Growth; Margins Slip

C

CNBC TV18•11-02-2026, 20:04

AstraZeneca Pharma Q3 Revenue Soars 39% on Oncology, Biopharma Growth; Margins Slip

•AstraZeneca Pharma India reported a 39% year-on-year revenue increase to ₹611.5 crore in Q3 FY26.
•Net profit rose 5.9% to ₹32.6 crore, despite weakening profitability metrics.
•Operating performance faced pressure, with EBITDA declining 41.7% to ₹44.8 crore and margins contracting to 7.3%.
•Topline growth was driven by strong performance in Oncology, Biopharmaceuticals (CVRM, R&I, V&I), and Rare Disease segments.
•The company secured eight new regulatory approvals in the past nine months, enhancing its India portfolio.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

निवेशकों के लिए असर क्या होता है?
शेयर एक्सचेंज रेशियो (Swap Ratio) मर्ज हो रहे बैंक के शेयर नए बैंक के शेयर में कन्वर्ट हो जाते हैं. जैसे: 100 शेयर = 75 शेयर (उदाहरण मात्र). शेयर प्राइस पर असर मर्जर घोषणा के बाद volatility बढ़ती है - कभी sharp jump, कभी profit booking.लंबी अवधि में फायदा

Q3 Results: 7 Companies See Earnings Boost, One Doubles Profit

Fortis Healthcare Q3 Profit Dips 21.9% Despite Strong Revenue Growth, Hospital Biz Up 14%

Fortis Healthcare Q3 Profit Dips 21.9% Despite Strong Revenue Growth, Hospital Biz Up 14%

BEML Q3 Results सरकारी इंजीनियरिंग कंपनी बीईएमएल (BEML) ने कारोबारी साल की तीसरी तिमाही (Q3) के नतीजे जारी किए हैं.

Pharma Q3: Eris, IPCA Soar, Blue Jet Profit Jumps 59.6% Amid Revenue Dip

Q3 Results: Tilaknagar Industries Swings to ₹105 Cr Loss; Mixed Performance Across Sectors

Q3 Results: Tilaknagar Industries Swings to ₹105 Cr Loss; Mixed Performance Across Sectors

सरकारी कंपनी ने Engineers India का मुनाफा तीन गुना बढ़ा है।

15 Stocks to Watch on Feb 13: Quarterly Results, Dividends, Management Changes

Representational image (Image: News18)

Jyothy Labs Q3 Net Profit Dips 7.2% to Rs 81.12 Cr Amid Higher Expenses